$PPDI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PHARMACEUTICAL PRODUCT DEVELOPMENT INC. Get notifications about new insider transactions in PHARMACEUTICAL PRODUCT DEVELOPMENT INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.27 | 100 | 3,527 | 23,313 | 23.4 K to 23.3 K (-0.43 %) |
| May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.26 | 707 | 24,929 | 23,413 | 24.1 K to 23.4 K (-2.93 %) |
| May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.20 | 10,000 | 352,000 | 24,120 | 34.1 K to 24.1 K (-29.31 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.40 | 1,000 | 35,400 | 34,120 | 35.1 K to 34.1 K (-2.85 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.37 | 4,000 | 141,480 | 35,120 | 39.1 K to 35.1 K (-10.22 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.36 | 1,000 | 35,360 | 39,120 | 40.1 K to 39.1 K (-2.49 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.35 | 1,000 | 35,350 | 40,120 | 41.1 K to 40.1 K (-2.43 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.34 | 1,000 | 35,340 | 41,120 | 42.1 K to 41.1 K (-2.37 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.31 | 2,000 | 70,620 | 42,120 | 44.1 K to 42.1 K (-4.53 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.30 | 3,000 | 105,900 | 44,120 | 47.1 K to 44.1 K (-6.37 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.29 | 4,000 | 141,160 | 47,120 | 51.1 K to 47.1 K (-7.82 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.28 | 7,000 | 246,960 | 51,120 | 58.1 K to 51.1 K (-12.04 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.27 | 13,000 | 458,510 | 58,120 | 71.1 K to 58.1 K (-18.28 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.26 | 2,000 | 70,520 | 71,120 | 73.1 K to 71.1 K (-2.74 %) |
| May 22 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.25 | 26,880 | 947,520 | 73,120 | 100 K to 73.1 K (-26.88 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Option Exercise | M | 15.30 | 10,000 | 153,000 | 20,000 | |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Option Exercise | M | 14.95 | 20,000 | 299,000 | 0 | |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Option Exercise | M | 13.11 | 10,500 | 137,655 | 0 | |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.87 | 385 | 13,425 | 0 | 385 to 0 (-100.00 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.88 | 1,700 | 59,296 | 385 | 2.1 K to 385 (-81.53 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.89 | 1,015 | 35,413 | 2,085 | 3.1 K to 2.1 K (-32.74 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.91 | 2,000 | 69,820 | 3,100 | 5.1 K to 3.1 K (-39.22 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.92 | 2,500 | 87,300 | 5,100 | 7.6 K to 5.1 K (-32.89 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.93 | 2,300 | 80,339 | 7,600 | 9.9 K to 7.6 K (-23.23 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.94 | 4,100 | 143,254 | 9,900 | 14 K to 9.9 K (-29.29 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.95 | 4,000 | 139,800 | 14,000 | 18 K to 14 K (-22.22 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.96 | 900 | 31,464 | 18,000 | 18.9 K to 18 K (-4.76 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.97 | 2,600 | 90,922 | 18,900 | 21.5 K to 18.9 K (-12.09 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.98 | 3,700 | 129,426 | 21,500 | 25.2 K to 21.5 K (-14.68 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 34.99 | 10,451 | 365,680 | 25,200 | 35.7 K to 25.2 K (-29.31 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 35.00 | 3,949 | 138,215 | 35,651 | 39.6 K to 35.7 K (-9.97 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Sell | S | 35.01 | 900 | 31,509 | 39,600 | 40.5 K to 39.6 K (-2.22 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Buy | M | 15.30 | 10,000 | 153,000 | 40,500 | 30.5 K to 40.5 K (+32.79 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Buy | M | 14.95 | 20,000 | 299,000 | 30,500 | 10.5 K to 30.5 K (+190.48 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | HARTMAN JUDD | General Counsel | Buy | M | 13.11 | 10,500 | 137,655 | 10,500 | 0 to 10.5 K |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.05 | 8,214 | 287,901 | 100,000 | 108.2 K to 100 K (-7.59 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.00 | 31,296 | 1,095,360 | 108,214 | 139.5 K to 108.2 K (-22.43 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.97 | 7,700 | 269,269 | 139,510 | 147.2 K to 139.5 K (-5.23 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.96 | 2,790 | 97,538 | 147,210 | 150 K to 147.2 K (-1.86 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.52 | 5,000 | 172,600 | 150,000 | 155 K to 150 K (-3.23 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.51 | 3,714 | 128,170 | 155,000 | 158.7 K to 155 K (-2.34 %) |
| May 21 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.50 | 41,286 | 1,424,367 | 158,714 | 200 K to 158.7 K (-20.64 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MAGNUSON TERRY | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | KLEMA CATHY | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | FRANK FRED | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | BONDURANT STUART | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.61 | 1,700 | 58,837 | 200,000 | 201.7 K to 200 K (-0.84 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.60 | 6,027 | 208,534 | 201,700 | 207.7 K to 201.7 K (-2.90 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.58 | 2,200 | 76,076 | 207,727 | 209.9 K to 207.7 K (-1.05 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.57 | 400 | 13,828 | 209,927 | 210.3 K to 209.9 K (-0.19 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.56 | 2,000 | 69,120 | 210,327 | 212.3 K to 210.3 K (-0.94 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.55 | 665 | 22,976 | 212,327 | 213 K to 212.3 K (-0.31 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.54 | 2,000 | 69,080 | 212,992 | 215 K to 213 K (-0.93 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.53 | 500 | 17,265 | 214,992 | 215.5 K to 215 K (-0.23 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.52 | 1,000 | 34,520 | 215,492 | 216.5 K to 215.5 K (-0.46 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.51 | 4,400 | 151,844 | 216,492 | 220.9 K to 216.5 K (-1.99 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.50 | 12,000 | 414,000 | 220,892 | 232.9 K to 220.9 K (-5.15 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.49 | 2,200 | 75,878 | 232,892 | 235.1 K to 232.9 K (-0.94 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.48 | 5,360 | 184,813 | 235,092 | 240.5 K to 235.1 K (-2.23 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.47 | 300 | 10,341 | 240,452 | 240.8 K to 240.5 K (-0.12 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.46 | 400 | 13,784 | 240,752 | 241.2 K to 240.8 K (-0.17 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.45 | 100 | 3,445 | 241,152 | 241.3 K to 241.2 K (-0.04 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.44 | 2,000 | 68,880 | 241,252 | 243.3 K to 241.3 K (-0.82 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.43 | 2,300 | 79,189 | 243,252 | 245.6 K to 243.3 K (-0.94 %) |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | FOX MARYE ANNE | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | MCNEILL JOHN A JR | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.01 | 200 | 6,802 | 8,683,960 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.00 | 500 | 17,000 | 8,684,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.99 | 1,500 | 50,985 | 8,684,660 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.98 | 700 | 23,786 | 8,686,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.97 | 700 | 23,779 | 8,686,860 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.96 | 800 | 27,168 | 8,687,560 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.95 | 400 | 13,580 | 8,688,360 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.94 | 100 | 3,394 | 8,688,760 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.93 | 200 | 6,786 | 8,688,860 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.92 | 100 | 3,392 | 8,689,060 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.89 | 200 | 6,778 | 8,689,160 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.88 | 200 | 6,776 | 8,689,360 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.84 | 100 | 3,384 | 8,689,560 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.82 | 700 | 23,674 | 8,689,660 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.81 | 800 | 27,048 | 8,690,360 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.80 | 612 | 20,686 | 8,691,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.79 | 1,188 | 40,143 | 8,691,772 | 8.7 M to 8.7 M (-0.01 %) |
| May 17 2007 | PPDI | PHARMACEUTICAL PRO ... | Wilkinson Peter J | VP of Fin./Chief Ac ... | Option Exercise | A | 33.82 | 15,000 | 507,300 | 15,000 | |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.78 | 1,000 | 33,780 | 8,692,960 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.76 | 1,900 | 64,144 | 8,693,960 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.75 | 100 | 3,375 | 8,695,860 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.74 | 2,400 | 80,976 | 8,695,960 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.73 | 2,702 | 91,138 | 8,698,360 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.72 | 1,398 | 47,141 | 8,701,062 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.71 | 3,100 | 104,501 | 8,702,460 | 8.7 M to 8.7 M (-0.04 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.70 | 500 | 16,850 | 8,705,560 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.69 | 1,692 | 57,003 | 8,706,060 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.68 | 854 | 28,763 | 8,707,752 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.67 | 1,062 | 35,758 | 8,708,606 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.66 | 2,600 | 87,516 | 8,709,668 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.65 | 892 | 30,016 | 8,712,268 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.64 | 900 | 30,276 | 8,713,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.63 | 1,100 | 36,993 | 8,714,060 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.62 | 2,400 | 80,688 | 8,715,160 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.61 | 4,200 | 141,162 | 8,717,560 | 8.7 M to 8.7 M (-0.05 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.60 | 5,300 | 178,080 | 8,721,760 | 8.7 M to 8.7 M (-0.06 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.59 | 6,290 | 211,281 | 8,727,060 | 8.7 M to 8.7 M (-0.07 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.58 | 5,410 | 181,668 | 8,733,350 | 8.7 M to 8.7 M (-0.06 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.57 | 2,685 | 90,135 | 8,738,760 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.56 | 1,915 | 64,267 | 8,741,445 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.55 | 5,200 | 174,460 | 8,743,360 | 8.7 M to 8.7 M (-0.06 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.54 | 6,700 | 224,718 | 8,748,560 | 8.8 M to 8.7 M (-0.08 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.53 | 2,300 | 77,119 | 8,755,260 | 8.8 M to 8.8 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.52 | 1,500 | 50,280 | 8,757,560 | 8.8 M to 8.8 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.51 | 3,664 | 122,781 | 8,759,060 | 8.8 M to 8.8 M (-0.04 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.50 | 2,570 | 86,095 | 8,762,724 | 8.8 M to 8.8 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.49 | 1,900 | 63,631 | 8,765,294 | 8.8 M to 8.8 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.48 | 100 | 3,348 | 8,767,194 | 8.8 M to 8.8 M (0.00 %) |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Option Exercise | M | 21.19 | 16,751 | 354,954 | 75,000 | |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 34.44 | 15,596 | 537,126 | 28,000 | 43.6 K to 28 K (-35.77 %) |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 34.50 | 1,155 | 39,848 | 43,596 | 44.8 K to 43.6 K (-2.58 %) |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Buy | M | 21.19 | 16,751 | 354,954 | 44,751 | 28 K to 44.8 K (+59.83 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.14 | 4,395 | 150,045 | 245,552 | 249.9 K to 245.6 K (-1.76 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.15 | 32,000 | 1,092,800 | 249,947 | 281.9 K to 249.9 K (-11.35 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.16 | 12,000 | 409,920 | 281,947 | 293.9 K to 281.9 K (-4.08 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.17 | 19,000 | 649,230 | 293,947 | 312.9 K to 293.9 K (-6.07 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.18 | 2,000 | 68,360 | 312,947 | 314.9 K to 312.9 K (-0.64 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.19 | 1,000 | 34,190 | 314,947 | 315.9 K to 314.9 K (-0.32 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.20 | 5,000 | 171,000 | 315,947 | 320.9 K to 315.9 K (-1.56 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.21 | 5,000 | 171,050 | 320,947 | 325.9 K to 320.9 K (-1.53 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.22 | 7,000 | 239,540 | 325,947 | 332.9 K to 325.9 K (-2.10 %) |
| May 10 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.23 | 3,000 | 102,690 | 332,947 | 335.9 K to 332.9 K (-0.89 %) |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.51 | 1,000 | 34,510 | 335,947 | 336.9 K to 335.9 K (-0.30 %) |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.52 | 1,505 | 51,953 | 336,947 | 338.5 K to 336.9 K (-0.44 %) |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.50 | 7,100 | 244,950 | 338,452 | 345.6 K to 338.5 K (-2.05 %) |
| May 09 2007 | PPDI | PHARMACEUTICAL PRO ... | MCNEILL JOHN A JR | Director | Gift | G | 0.00 | 12,919 | 0 | 3,090,060 | 3.1 M to 3.1 M (-0.42 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.51 | 4,600 | 158,746 | 345,552 | 350.2 K to 345.6 K (-1.31 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.52 | 5,000 | 172,600 | 350,152 | 355.2 K to 350.2 K (-1.41 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.53 | 11,000 | 379,830 | 355,152 | 366.2 K to 355.2 K (-3.00 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.54 | 9,000 | 310,860 | 366,152 | 375.2 K to 366.2 K (-2.40 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.55 | 13,000 | 449,150 | 375,152 | 388.2 K to 375.2 K (-3.35 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.56 | 4,000 | 138,240 | 388,152 | 392.2 K to 388.2 K (-1.02 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.57 | 13,000 | 449,410 | 392,152 | 405.2 K to 392.2 K (-3.21 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.58 | 1,000 | 34,580 | 405,152 | 406.2 K to 405.2 K (-0.25 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.59 | 16,000 | 553,440 | 406,152 | 422.2 K to 406.2 K (-3.79 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.61 | 6,000 | 207,660 | 422,152 | 428.2 K to 422.2 K (-1.40 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.62 | 4,000 | 138,480 | 428,152 | 432.2 K to 428.2 K (-0.93 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.63 | 2,000 | 69,260 | 432,152 | 434.2 K to 432.2 K (-0.46 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.64 | 2,000 | 69,280 | 434,152 | 436.2 K to 434.2 K (-0.46 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.65 | 1,000 | 34,650 | 436,152 | 437.2 K to 436.2 K (-0.23 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.66 | 1,000 | 34,660 | 437,152 | 438.2 K to 437.2 K (-0.23 %) |
| May 08 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 34.67 | 2,000 | 69,340 | 438,152 | 440.2 K to 438.2 K (-0.45 %) |